Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | INSP | Common Stock | Options Exercise | $5.91K | +2.85K | +1150.81% | $2.07* | 3.1K | Dec 23, 2021 | Direct | F1 |
transaction | INSP | Common Stock | Options Exercise | $5.16K | +5.49K | +176.92% | $0.94* | 8.59K | Dec 23, 2021 | Direct | |
transaction | INSP | Common Stock | Sale | -$2M | -8.34K | -97.11% | $240.00 | 248 | Dec 23, 2021 | Direct | F2 |
transaction | INSP | Common Stock | Options Exercise | $1.34K | +646 | +260.48% | $2.07* | 894 | Dec 27, 2021 | Direct | |
transaction | INSP | Common Stock | Options Exercise | $726 | +772 | +86.35% | $0.94* | 1.67K | Dec 27, 2021 | Direct | |
transaction | INSP | Common Stock | Sale | -$340K | -1.42K | -85.11% | $240.00 | 248 | Dec 27, 2021 | Direct | F2 |
holding | INSP | Common Stock | 167 | Dec 23, 2021 | By son | ||||||
holding | INSP | Common Stock | 166 | Dec 23, 2021 | By daughter |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | INSP | Stock Option (Right to Buy) | Options Exercise | $0 | -2.85K | -23.65% | $0.00 | 9.21K | Dec 23, 2021 | Common Stock | 2.85K | $2.07 | Direct | F3 |
transaction | INSP | Stock Option (Right to Buy) | Options Exercise | $0 | -5.49K | -40.55% | $0.00 | 8.05K | Dec 23, 2021 | Common Stock | 5.49K | $0.94 | Direct | F3, F4 |
transaction | INSP | Stock Option (Right to Buy) | Options Exercise | $0 | -646 | -7.01% | $0.00 | 8.57K | Dec 27, 2021 | Common Stock | 646 | $2.07 | Direct | F3 |
transaction | INSP | Stock Option (Right to Buy) | Options Exercise | $0 | -772 | -9.6% | $0.00 | 7.27K | Dec 27, 2021 | Common Stock | 772 | $0.94 | Direct | F3 |
Id | Content |
---|---|
F1 | Includes 19 additional shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on January 6, 2021. |
F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan dated November 5, 2021. |
F3 | The option is fully vested and exercisable. |
F4 | This option grant was previously reported as having an expiration date of December 31, 2026, which has been revised herein. |